Cardiovascular prevention tools
The right LDL goal, and the medicines to reach it.
11well builds clinical decision support for primary care and cardiology teams, grounded in the current guidelines and the trials behind them. Every recommendation shows its source.
LDL-C goals, 2026 guideline
Borderline or intermediate 10-year risk, diabetes, CAC 1–99
High risk (≥10%), CAC ≥100, clinical ASCVD
Very high-risk ASCVD, ASCVD with CKD, CAC ≥1000
Simplified. The tool applies the full rules, including FH and triglycerides.
LDL Goal Navigator
Answer only the questions that can change the goal or the medicines. Known ASCVD takes a handful of fields; primary prevention adds CAC and the PREVENT score.
From chart data to a treatment plan
Enter the values or launch it from Epic. You get an LDL-C goal, statin intensity and starting doses, the expected LDL-C after each step, and when to recheck.
Open the tool- PathwayClinical ASCVD, LDL-C ≥190 or familial hypercholesterolemia, or primary prevention.
- Coronary artery calciumUsed for every primary-prevention patient to set the goal.
- 10-year riskCalculate with the AHA PREVENT equations, or enter the score already in the chart.
- Goal and medicinesStatin first, then ezetimibe, then a PCSK9 antibody, with a separate path for statin intolerance.
Built on the evidence
2026 ACC/AHA multisociety dyslipidemia guideline, the PREVENT equations (Khan et al., Circulation 2024) and outcome trials such as IMPROVE-IT, FOURIER and CLEAR Outcomes.
Shows its reasoning
Each step lists its source and class of recommendation. Where evidence is unclear, the tool flags it for the clinician instead of guessing.
Data stays with you
Calculations run in your browser. Patient information is not sent to or stored on this site.
For clinicians. LDL Goal Navigator is decision support. It does not replace clinical judgment, is not FDA-cleared, and is under validation. Review every recommendation before acting on it.